Cargando…

Minimally-Invasive Secondary Cytoreduction in Recurrent Ovarian Cancer

SIMPLE SUMMARY: Ovarian cancer (OC) represents one of the most lethal cancers in women, with most cases diagnosed at an advanced stage. Recurrence occurs in around 70% of women within 5 years of diagnosis. In this era, in which maintenance therapy with PARP-inhibitors is the standard of care, most r...

Descripción completa

Detalles Bibliográficos
Autores principales:	Certelli, Camilla, Russo, Silvio Andrea, Palmieri, Luca, Foresta, Aniello, Pedone Anchora, Luigi, Vargiu, Virginia, Santullo, Francesco, Fagotti, Anna, Scambia, Giovanni, Gallotta, Valerio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2023
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10571765/ https://www.ncbi.nlm.nih.gov/pubmed/37835463 http://dx.doi.org/10.3390/cancers15194769

Ejemplares similares

Special Issue: “Management of Early Stage Cervical Cancer”
por: Certelli, Camilla, et al.
Publicado: (2023)

Cytoreductive Surgery Plus Platinum-Based Hyperthermic Intraperitoneal Chemotherapy in Epithelial Ovarian Cancer: A Promising Integrated Approach to Improve Locoregional Control
por: Petrillo, Marco, et al.
Publicado: (2016)

Risk Factors for Anastomotic Leakage in Advanced Ovarian Cancer Surgery: A Large Single-Center Experience
por: Costantini, Barbara, et al.
Publicado: (2022)

Ultrastaging of the Parametrium in Cervical Cancer: A Clinicopathological Study
por: Bizzarri, Nicolò, et al.
Publicado: (2023)

Update on the secondary cytoreduction in platinum-sensitive recurrent ovarian cancer: a narrative review
por: Conte, Carmine, et al.
Publicado: (2021)

Impact of surgeon learning curve in minimally invasive radical hysterectomy on early stage cervical cancer patient survival
por: Pedone Anchora, L, et al.
Publicado: (2021)

Beyond sentinel node algorithm. Toward a more tailored surgery for cervical cancer patients
por: Fagotti, Anna, et al.
Publicado: (2016)

Should the Number of Metastatic Pelvic Lymph Nodes Be Integrated into the 2018 Figo Staging Classification of Early Stage Cervical Cancer?
por: Pedone Anchora, Luigi, et al.
Publicado: (2020)

Sentinel lymph node mapping with indocyanine green in cervical cancer patients undergoing open radical hysterectomy: a single-institution series
por: Bizzarri, Nicolò, et al.
Publicado: (2020)

Prognostic Significance of Ultrasound Characteristics and Body Mass Index in Patients with Apparent Early-Stage Cervical Cancer: A Single-Center, Retrospective, Cohort Study
por: Bizzarri, Nicolò, et al.
Publicado: (2023)

Pharmacokinetics of cisplatin during open and minimally-invasive secondary cytoreductive surgery plus HIPEC in women with platinum-sensitive recurrent ovarian cancer: a prospective study
por: Petrillo, Marco, et al.
Publicado: (2019)

The first European gynaecological procedure with the new surgical robot Hugo™ RAS. A total hysterectomy and salpingo-oophorectomy in a woman affected by BRCA-1 mutation
por: Monterossi, G, et al.
Publicado: (2022)

Near-Infrared Imaging With Indocyanine Green for the Treatment of Endometriosis: Results From the Gre-Endo Trial
por: Turco, Luigi Carlo, et al.
Publicado: (2021)

Polarisation of Tumor-Associated Macrophages toward M2 Phenotype Correlates with Poor Response to Chemoradiation and Reduced Survival in Patients with Locally Advanced Cervical Cancer
por: Petrillo, Marco, et al.
Publicado: (2015)

p53 overexpression is associated with cytoreduction and response to chemotherapy in ovarian cancer
por: Ferrandina, G, et al.
Publicado: (1999)

Extreme complications related to bevacizumab use in the treatment of ovarian cancer: a case series from a III level referral centre and review of the literature
por: Turco, Luigi Carlo, et al.
Publicado: (2020)

Clinical Impact of Pathologic Residual Tumor in Locally Advanced Cervical Cancer Patients Managed by Chemoradiotherapy Followed by Radical Surgery: A Large, Multicenter, Retrospective Study
por: Federico, Alex, et al.
Publicado: (2022)

Total Microlaparoscopic Radical Hysterectomy in Early Cervical Cancer
por: Fanfani, Francesco, et al.
Publicado: (2013)

Minimally Invasive Approaches in Locally Advanced Cervical Cancer Patients Undergoing Radical Surgery After Chemoradiotherapy: A Propensity Score Analysis
por: Ferrandina, G., et al.
Publicado: (2020)

Concordance of Radiological, Laparoscopic and Laparotomic Scoring to Predict Complete Cytoreduction in Women with Advanced Ovarian Cancer
por: Di Donna, Mariano Catello, et al.
Publicado: (2023)

Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial
por: Ferrandina, G, et al.
Publicado: (2009)

Laparoendoscopic Single-Site Surgery for the Treatment of Benign Adnexal Disease: A Prospective Trial
por: Fagotti, Anna, et al.
Publicado: (2010)

Indocyanine Green to Assess Vascularity of Ileal Conduit Anastomosis During Pelvic Exenteration for Recurrent/Persistent Gynecological Cancer: A Pilot Study
por: Bizzarri, Nicolò, et al.
Publicado: (2021)

Recurrent ectopic pregnancy on tubal remnant treated by laparoscopic resection: loop and stitch
por: Restaino, S, et al.
Publicado: (2021)

Radiomic models for lymph node metastasis prediction in cervical cancer: can we think beyond sentinel lymph node?
por: Bizzarri, Nicolò, et al.
Publicado: (2021)

The current role of secondary cytoreductive surgery for recurrent ovarian cancer
por: de Bree, Eelco, et al.
Publicado: (2022)

Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis
por: Mantegna, Giovanna, et al.
Publicado: (2013)

Artificial intelligence weights the importance of factors predicting complete cytoreduction at secondary cytoreductive surgery for recurrent ovarian cancer
por: Bogani, Giorgio, et al.
Publicado: (2018)

Simplified Selection Criteria for Secondary Cytoreductive Surgery in Recurrent Ovarian Cancer
por: Son, Joo-Hyuk, et al.
Publicado: (2022)

Laparoscopic selection for surgery in epithelial ovarian cancer. A short review
por: Ghirardi, v, et al.
Publicado: (2023)

Cytoreductive surgery in ovarian cancer
por: Pomel, Christophe, et al.
Publicado: (2007)

Secondary cytoreductive surgery for recurrent epithelial ovarian carcinoma: proposal for patients selection
por: Onda, T, et al.
Publicado: (2005)

Secondary cytoreduction surgery improves prognosis in platinum-sensitive recurrent ovarian cancer
por: Xu, Xia, et al.
Publicado: (2013)

Which patients benefit from secondary cytoreductive surgery in recurrent ovarian cancer?
por: Zang, Rongyu, et al.
Publicado: (2019)

Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study
por: Corrado, Giacomo, et al.
Publicado: (2020)

HPV and Cytology Testing in Women Undergoing 9-Valent HPV Opportunistic Vaccination: A Single-Cohort Follow Up Study
por: De Vincenzo, Rosa, et al.
Publicado: (2021)

Cytoreductive Surgery (CRS) and HIPEC for Advanced Ovarian Cancer with Peritoneal Metastases: Italian PSM Oncoteam Evidence and Study Purposes
por: Marrelli, Daniele, et al.
Publicado: (2022)

Prediction Models for Complete Resection in Secondary Cytoreductive Surgery of Patients With Recurrent Ovarian Cancer
por: Jiang, Caixia, et al.
Publicado: (2021)

A score system for complete cytoreduction in selected recurrent ovarian cancer patients undergoing secondary cytoreductive surgery: predictors- and nomogram-based analyses
por: Bogani, Giorgio, et al.
Publicado: (2018)

Is the sarcomatous component (homologous vs heterologous) the prognostic “driving force” in early-stage uterine carcinosarcomas? A retrospective multicenter study
por: Rosati, A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_nc7r84ke22as24k2ag922b4bp1